. Author manuscript; available in PMC: 2021 Sep 14.

Published in final edited form as: J Allergy Clin Immunol. 2020 Feb;145(2):550–562. doi: 10.1016/j.jaci.2019.10.031

TABLE I.

Clinical correlations of miR-1 levels in asthmatic patients (n = 70)

Variable
Age	P = .4158, r = −0.0988
Sex	P = .351
Atopy	P = .4711
Hospitalization for asthma (lifetime)	P = .0047, r = −0.3339
Hospitalization for asthma (past year)	P = .0163, r = −0.2862
ACT score	P = .0158, r = 0.2875
FEV₁ (% predicted)^*	P = .0007, r = 0.3996
FVC (% predicted)^*	P = .0008, r = 0.3961
OCS use	P = .2082, r = −0.1523
ICS use	P = .0039, r = −0.3409
Sputum cytology^†
Eosinophils	P = .0132, r = −0.3037
Neutrophils	P = .0778, r = −0.2187
Macrophages	P = .8875, r = −0.01774
Lymphocytes	P = .9132, r = 0.01368

ACT, Asthma Control Test; FVC, forced vital capacity; ICS, inhaled corticosteroid; OCS, oral corticosteroid.

Data are available for 68 subjects.

^†

Data are available for 66 subjects.